GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tofflon Science and Technology Group Co 300171.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

13.88

+1.39%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥5.23bn

FY2016FY2025

Net income

CN¥200.4m

FY2016FY2025

Free cash flow

CN¥459.6m

FY2016FY2025

Shareholders' equity

CN¥7.93bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥5.23bnCN¥5.01bnCN¥5.64bnCN¥5.47bnCN¥4.19bnCN¥2.71bnCN¥2.26bnCN¥1.92bnCN¥1.72bnCN¥1.33bn
Gross profitCN¥1.54bnCN¥1.30bnCN¥1.89bnCN¥2.09bnCN¥1.90bnCN¥1.10bnCN¥725.1mCN¥569.5mCN¥596.2mCN¥554.1m
Research and developmentCN¥337.7mCN¥346.3mCN¥379.5mCN¥332.8mCN¥284.5mCN¥156.1mCN¥119.0mCN¥97.7mCN¥113.2mCN¥92.5m
Operating incomeCN¥325.2mCN¥215.7mCN¥702.8mCN¥999.2mCN¥1.02bnCN¥548.8mCN¥187.0mCN¥112.6mCN¥166.0mCN¥261.8m
Net incomeCN¥200.4mCN¥194.1mCN¥600.2mCN¥846.6mCN¥827.8mCN¥463.5mCN¥145.8mCN¥70.5mCN¥123.1mCN¥234.5m
Diluted earnings per share0.260.260.791.301.290.740.230.110.200.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥13.51bnCN¥13.07bnCN¥12.90bnCN¥13.38bnCN¥9.74bnCN¥6.58bnCN¥5.21bnCN¥4.69bnCN¥4.37bnCN¥4.20bn
Cash and short-term investments—CN¥2.96bnCN¥2.83bnCN¥4.99bnCN¥3.82bnCN¥3.10bnCN¥2.12bnCN¥565.5mCN¥783.3mCN¥889.2m
Total liabilitiesCN¥5.34bnCN¥5.02bnCN¥4.79bnCN¥5.73bnCN¥5.26bnCN¥2.89bnCN¥1.97bnCN¥1.57bnCN¥1.28bnCN¥1.20bn
DebtCN¥70.8mCN¥9.8mCN¥3.9mCN¥5.6mCN¥8.2mCN¥3.1mCN¥2.9mCN¥12.3mCN¥65.6mCN¥5.0m
Shareholders' equityCN¥7.93bnCN¥7.81bnCN¥7.88bnCN¥7.44bnCN¥4.32bnCN¥3.60bnCN¥3.15bnCN¥3.03bnCN¥2.99bnCN¥2.92bn
Shares outstanding761m754m761m649m640m628m627m628m628m623m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥730.8mCN¥880.6m−CN¥312.4mCN¥247.2mCN¥1.37bnCN¥1.12bnCN¥446.3mCN¥222.0mCN¥20.9mCN¥107.4m
Capital spending−CN¥271.2m−CN¥498.5m−CN¥694.6m−CN¥725.7m−CN¥454.1m−CN¥26.7m−CN¥14.0m−CN¥32.0m−CN¥36.5m−CN¥9.2m
Free cash flowCN¥459.6mCN¥382.1m−CN¥1.01bn−CN¥478.6mCN¥914.8mCN¥1.09bnCN¥432.3mCN¥190.0m−CN¥15.6mCN¥98.2m
Dividends paid−CN¥82.0m−CN¥182.3m−CN¥249.3m−CN¥245.1m−CN¥138.2m−CN¥44.0m−CN¥25.1m−CN¥15.0m−CN¥159.2m−CN¥76.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.43bnCN¥1.11bnCN¥1.53bnCN¥1.28bnCN¥1.29bnCN¥1.14bnCN¥1.52bnCN¥1.20bn
Gross profitCN¥476.4mCN¥338.9mCN¥393.3mCN¥440.1mCN¥343.5mCN¥278.1mCN¥275.6mCN¥391.1m
Operating incomeCN¥192.8mCN¥66.4mCN¥67.3mCN¥89.3mCN¥49.6mCN¥20.3mCN¥40.5mCN¥76.9m
Net incomeCN¥80.2mCN¥27.5mCN¥68.8mCN¥85.7mCN¥25.8mCN¥20.1mCN¥41.3mCN¥38.8m
Diluted earnings per share0.110.040.090.110.030.030.050.05
Cash from operations———CN¥47.0mCN¥285.0m−CN¥9.0m—CN¥236.0m
Capital spending−CN¥22.0m−CN¥44.0m−CN¥41.0m−CN¥53.0m−CN¥49.0m−CN¥126.0m−CN¥125.0m−CN¥102.0m
Free cash flow———−CN¥6.0mCN¥236.0m−CN¥135.0m—CN¥134.0m
Total assetsCN¥13.61bnCN¥13.56bnCN¥13.51bnCN¥13.30bnCN¥13.24bnCN¥13.03bnCN¥13.07bnCN¥13.08bn
Cash and short-term investments———CN¥3.60bnCN¥3.36bnCN¥3.15bnCN¥2.96bnCN¥2.93bn
DebtCN¥90.4mCN¥85.9mCN¥70.8mCN¥19.5mCN¥49.7mCN¥24.8mCN¥8.0mCN¥3.0m
Shareholders' equityCN¥7.97bnCN¥7.96bnCN¥7.93bnCN¥7.85bnCN¥7.79bnCN¥7.83bnCN¥7.81bnCN¥7.83bn

Financial ratios

Data as of 4 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY2015
Gross margin29.3%26.0%33.4%38.2%45.4%40.6%———
Operating margin6.2%4.3%12.5%18.3%24.2%20.3%———
Net margin3.8%3.9%10.6%15.5%19.7%17.1%———
Return on equity2.5%2.5%7.6%11.4%19.2%12.9%———
Return on assets1.5%1.5%4.7%6.3%8.5%7.0%———
Free cash flow yield8.0%11.1%3.1%9.1%17.3%11.1%———
Revenue growth4.4%-11.2%3.1%30.5%54.8%19.6%———
Earnings growth3.2%-67.7%-29.1%2.3%78.6%217.9%———
Current ratio1.98x1.99x1.92x2.01x1.63x2.07x———
Debt to equity0.01x0.00x0.00x———0.00x0.00x0.00x
Equity ratio58.7%59.7%61.1%55.6%44.4%54.8%———
Interest coverage196.23x68.55x200.81x288.48x409.93x413.57x———
R&D as a share of sales6.5%6.9%6.7%6.1%6.8%5.8%———
Buybacks as a share of market value-1.0%0.9%-17.3%-1.4%-1.8%-0.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.5%14.1%12.9%
Operating income-31.2%-9.9%-2.9%
Net income-38.1%-15.4%-6.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.7%31.9%34.7%35.0%
Operating margin5.3%10.5%13.5%13.4%
Net margin3.9%8.6%11.1%11.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings59.651.622.818.239.021.930.562.549.939.6
Price to sales2.32.02.42.87.73.82.02.33.67.0

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 10 Sept 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.1460.1060.2390.3280.3860.220.070.04
  • 2-for-1 split · 19 Jun 2015
  • 1.488-for-1 split · 9 Jul 2014
  • 13-for-10 split · 28 May 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.